adhd meds and glp 1 Impact of Glucagon-like Peptide-1 Receptor Agonists on Mental Illness: Evidence from a Mendelian Randomization Study adhd meds and glp 1

Harada, Effects of metformin on blood glucose levels and bodyweight mediated through intestinal effects

Meta-analyses have confirmed the benefit of GLP-1 RAs as a class in both secondary and primary prevention of cardiovascular disease, and in reduction of adverse kidney outcomes in people with T2D (Kristiensen et al, 2019

Multiple large-scale clinical trials have demonstrated that GLP-1 receptor agonists significantly reduce major adverse cardiovascular events, cardiovascular death, and all-cause mortality in patients with Type 2 diabetes

doi: 10.3389/fendo.2021.814770 41 KlemetsAReppoIKrigulKLVolkeVAasmetsOOrgE

the documented protocol uses a single weekly injection on a consistent day, not daily dosing

J Diabetes Res 2022;2022:9723632